Follow
Heloisa Helena Milioli
Title
Cited by
Cited by
Year
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
HH Milioli, I Tishchenko, C Riveros, R Berretta, P Moscato
BMC medical genomics 10 (1), 1-17, 2017
722017
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer
Nature Medicine, 1-11, 2021
54*2021
The discovery of novel biomarkers improves breast cancer intrinsic subtype prediction and reconciles the labels in the metabric data set
HH Milioli, R Vimieiro, C Riveros, I Tishchenko, R Berretta, P Moscato
PloS one 10 (7), e0129711, 2015
322015
Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion
HH Milioli, KS Sousa, R Kaviski, NCDS Oliveira, CDA Urban, RS De Lima, ...
Cancer Genomics & Proteomics 12 (2), 89-101, 2015
242015
Non-canonical AR activity facilitates endocrine resistance in breast cancer
KM Chia, H Milioli, N Portman, G Laven-Law, R Coulson, A Yong, ...
Endocrine-related cancer 26 (2), 251-264, 2019
212019
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
N Portman, HH Milioli, S Alexandrou, R Coulson, A Yong, KJ Fernandez, ...
Breast Cancer Research 22 (1), 1-17, 2020
182020
Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset
HH Milioli, R Vimieiro, I Tishchenko, C Riveros, R Berretta, P Moscato
BioData mining 9 (1), 1-8, 2016
182016
Extensive transcriptomic and genomic analysis provides new insights about luminal breast cancers
I Tishchenko, HH Milioli, C Riveros, P Moscato
PloS one 11 (6), e0158259, 2016
172016
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma
NC Oliveira, TH Gomig, HH Milioli, F Cordeiro, GG Costa, CA Urban, ...
Genet Mol Res 15 (2), 1-10, 2016
162016
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
B Heng, AA Bilgin, DB Lovejoy, VX Tan, HH Milioli, L Gluch, ...
Breast Cancer Research 22 (1), 1-14, 2020
122020
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets
HH Milioli, S Alexandrou, E Lim, CE Caldon
Endocrine-related cancer 27 (5), R93-R112, 2020
92020
Epigenetic therapy suppresses endocrine-resistant breast tumour growth by re-wiring ER-mediated 3D chromatin interactions
J Achinger-Kawecka, C Stirzaker, KM Chia, N Portman, E Campbell, Q Du, ...
bioRxiv, 2021
62021
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
E Lim, TA Hickey, LA Selth, KM Chia, HH Milioli, D Roden, G Laven-Law, ...
Cancer Research 80 (4 Supplement), GS2-03-GS2-03, 2020
12020
Abstract P40: Breast cancer molecular portraits of intrinsic subtypes and integrative clusters in the metabric data set
HH Milioli, C Sanhueza, R Berretta, P Moscato
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 12, 27-27, 2016
12016
The anti-androgen seviteronel sensitizes triple-negative breast cancer to chemotherapy
BPS Juan, S Hediyah-Zadeh, L Rangel, V Rodriguez, HH Milioli, ...
Cancer Research 82 (12_Supplement), 1029-1029, 2022
2022
Aggressive breast cancer subtype eats tryptophan!
B Heng, A Bilgin, V Tan, H Milioli, D Lovejoy, S Bustamante, L Gluch, ...
Asia-Pacific Journal of Clinical Oncology 17 (S5), 15-16, 2021
2021
Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
N Portman, H Milioli, S Alexandrou, R Coulson, A Yong, K Fernandez, ...
Cancer Research 81 (4_Supplement), PS18-17-PS18-17, 2021
2021
Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
N Portman, H Milioli, S Alexandrou, R Coulson, A Yong, K Fernandez, ...
CANCER RESEARCH 81 (4), 2021
2021
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
E Lim, HH Milioli, S Alexandrou, R Coulson, A Yong, KJ Fernandez, ...
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 16, 110-110, 2020
2020
The Androgen Receptor is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
W Tilley, T Hickey, L Selth, KM Chia, H Milioli, G Laven-Law, D Roden, ...
10.21203/rs.3.rs-62718/v1, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20